FDA
approval
· 2022-12-16
FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Supplemental Application (Alvogen Inc.)
Summary
FDA approved a supplemental application for the generic buprenorphine and naloxone sublingual film from Alvogen Inc., authorizing market authorization of this p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM (BUPRENORPHINE AND NALOXONE)